N-(2,5-dimethoxyphenyl)-7-(3,3,3-trifluoro-2,2-dihydroxypropanamido)heptanamide

ID: ALA5284307

Chembl Id: CHEMBL5284307

Max Phase: Preclinical

Molecular Formula: C18H25F3N2O6

Molecular Weight: 422.40

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(OC)c(NC(=O)CCCCCCNC(=O)C(O)(O)C(F)(F)F)c1

Standard InChI:  InChI=1S/C18H25F3N2O6/c1-28-12-8-9-14(29-2)13(11-12)23-15(24)7-5-3-4-6-10-22-16(25)17(26,27)18(19,20)21/h8-9,11,26-27H,3-7,10H2,1-2H3,(H,22,25)(H,23,24)

Standard InChI Key:  GGWIWBOMIDQQKA-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5284307

    ---

Associated Targets(Human)

HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Panel NCI-60 (60 carcinoma cell lines) (1088 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 422.40Molecular Weight (Monoisotopic): 422.1665AlogP: 1.95#Rotatable Bonds: 11
Polar Surface Area: 117.12Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.50CX Basic pKa: CX LogP: 1.96CX LogD: 0.99
Aromatic Rings: 1Heavy Atoms: 29QED Weighted: 0.32Np Likeness Score: -0.74

References

1. Riddhidev B, Endri K, Sabitri L, Kotsull Lauren N, Nishanth K, Dragan I, Mary Kay H P, James S, William T, L M Viranga T..  (2022)  Rational design of metabolically stable HDAC inhibitors: An overhaul of trifluoromethyl ketones.,  244  [PMID:36244186] [10.1016/j.ejmech.2022.114807]

Source